Showing results (411-420 of 760) with videos related to
Sort By:
Pageof 76
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.Blood|March 25, 2016
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1Paul G Richardson, Todd M Zimmerman, Craig C Hofmeister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX studyAsher Chanan-Khan, Pieter Sonneveld, Michael W Schuster, et al.Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.Blood|March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple MyelomaChandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.British Journal of Haematology|January 21, 2016
Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myelomaKay R Ting, Jennifer J Brady, Abdul Hameed, et al.Cancer Research Communications|September 8, 2023
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction TreatmentJiahui Liu, Wenqiang Yan, Huishou Fan, et al.Blood|June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaLaurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.British Journal of Haematology|July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomibReshma Shringarpure, Laurence Catley, Deepak Bhole, et al.Leukemia|July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myelomaLiang Lin, Shih-Feng Cho, Lijie Xing, et al.Pageof 76